Biofir Generasi 1

Kalung biofir asli bisa anda dapatkan di Biofirenergi.com. Biofir berfungsi menggetarkan molekul-molekul air (termasuk di dalam darah, sel, nutrisi, pembuluh darah, syaraf, dan organ-organ tubuh), menguraikan sel-sel darah yang kental menjadi sel-sel darah yang lebih encer. Apabila darah lebih encer maka otomatis peredaran darah menjadi lebih lancar, pengikatan oksigen dan nutrisi lebih maksimal, metabolisme tubuh lebih optimal dan yang penting kerja jantung menjadi lebih ringan.

Coba bayangkan kita menyedot jus alpukat yang kental pasti lebih berat dibandingkan yang encer. Sifat terapi yang alami inilah menjadikan terapi Biofir aman untuk anak-anak hingga lansia. Sangat dianjurkan untuk membantu proses kesembuhan dan meningkatkan kesehatan.

Kalung Biofir Asli adalah sebuah produk inovasi baru yang berasal dari penelitian beberapa profesor di Jepang, berbasis teknologi bio energi dari far infrared ray (sinar infra merah bio energi – BIOFIR).

Kalung Biofir Asli (Bio Necklace) adalah sebuah produk import yang berasal dari batuan lava gunung berapi, mengandung 26 unsur logam mulia yang memancarkan sinar infra merah jauh (far infrared ray). Disebut juga Bio Genetic karena reaksi gelombang sinar tersebut mampu menghidupkan materi fisiologi yang terbentuk dari molekul-molekul.

Saat sinar bio bertemu dengan materi, sinar bio memacu molekul-molekul bergetar semakin cepat dan kuat. Kekuatan daya tembusnya sangat kuat, reaksi hangatnya sangat bagus dan dapat menembus ke dalam jaringan bawah kuit, mengembangkan pembuluh darah halus dan menghidupkan sel-sel, melancarkan peredaradan darah dan metabolisme serta membuat badan menjadi lebih sehat.

Hati-hati dengan maraknya produk palsu yang ditawarkan di pusat-pusat keramaian (mall, airport, dll) terbuat dari plastik, keramik biasa atau besi magnet. Kalung Biofir Asli adalah keramik khusus, bukan plastik dan bukan besi magnet. Pastikan produk yang Anda beli Kalung Biofir Asli dalam segel dan hologram masih utuh.

Pastikan kalung biofir asli anda dengan membeli Biofirenergi.com

“We recognize that preparedness is shared responsibility between federal, tribal, state, local governments, private organizations and individuals. We are doing our part to be as prepared as possible for the impact that this infectious disease could have on our country,” Secretary Sebelius said. “Vaccines may serve an important role in that preparedness. The action we are taking today will provide flexibility in a future immunization program, if a program is recommended.”

The funds will be used to place additional orders for bulk H1N1 antigen and adjuvant on existing contracts with Sanofi Pasteur, MedImmune, GlaxoSmithKline and Novartis. The vaccine ingredients will become a part of the pandemic stockpile, for use if a vaccination campaign is necessary.

Antigen is the active ingredient in a vaccine that causes the human body’s immune system to develop antibodies that help fight an invading virus. Depending on the results of clinical studies, adjuvant could be added to a vaccine to boost the immune system’s response and potentially reduce the amount of antigen necessary for the body to recognize and fight a virus.

In May, Secretary Sebelius directed approximately $1 billion to be used for the development of a vaccine and for clinical studies to determine dose level and assess the safety and effectiveness of potential vaccines.

The Biomedical Advanced Research and Development Authority (BARDA) in the HHS Office of the Assistant Secretary for Preparedness and Response established the existing contracts with these companies in 2004 as part of the National Strategy for Pandemic Influenza.

A study released Oct. 2 by Harvard School of Public Health researchers found that only 40% of adults were “absolutely certain” they would get the H1N1 vaccine for themselves and 51% of parents were “absolutely certain” they would get the vaccine for their children. Children are among the designated priority groups to receive the vaccine.

But if the flu outbreak is severe in their own communities, those queried told researchers they might be more inclined to get the vaccine for themselves and their children. The survey was conducted Sept. 14-20 by telephone with a sample of 1,042 adults.

Those who were not “absolutely certain” they would get the H1N1 vaccine said they were concerned about possible side effects, did not think they were at risk of getting seriously ill from the virus or thought they could get medication to treat H1N1 if they got sick.

By late September, widespread H1N1 activity had been reported in 27 states, and the virus’ spread showed no signs of slowing, according to the CDC. If the increasing reach of the illness prompts more people to get the vaccine, tracking systems will help determine if anything unusual occurs.

VAERS, which is jointly managed by the CDC and the Food and Drug Administration, is ready to receive reports of events from physicians and others, said Claudia Vellozzi, MD, MPH, deputy director of the CDC’s Immunization Safety Office. Staff is being increased for the upcoming flu season to process reports more rapidly, she said.

But there are limitations to VAERS, Dr. Vellozzi said. The quality of the data varies, and there is no unvaccinated comparison group. There also is a great deal of underreporting, she said.

Some other tracking efforts include the Vaccine Safety Datalink project, a joint effort involving the CDC’s Immunization Safety Office and eight large managed care organizations.

A new tracking system, the Real Time Immunization Monitoring System, will use a Web-based system developed at Johns Hopkins Bloomberg School of Public Health to follow people for up to six weeks postvaccination.

The CDC and six academic medical centers with vaccine safety experts will provide clinical expertise in the evaluation of serious adverse events. The Dept. of Defense is monitoring 1.5 million active duty personnel. Another tracking component is Post-Licensure Rapid Immunization Safety Monitoring, a collaboration involving the National Vaccine Program Office, the FDA and the CDC.

About 600,000 doses of the nasal-spray H1N1 vaccine have been shipped and scheduled to arrive in early October in 25 states and cities, Dr. Schuchat said. Injectable vaccine was expected to be shipped soon after that.

People with the flu, particularly children and adolescents, may be at an increased risk of self injury and confusion shortly after taking TAMIFLU and should be closely monitored for signs of unusual behavior. A healthcare professional should be contacted immediately if the patient taking TAMIFLU shows any signs of unusual behavior.

The most common side effects of TAMIFLU are mild to moderate nausea and vomiting. TAMIFLU is generally well tolerated.

In addition, take the following precautions when using TAMIFLU:

• You should not take TAMIFLU if you are allergic to oseltamivir phosphate or any other ingredients of TAMIFLU.
• TAMIFLU is normally not recommended for use during pregnancy or nursing, as the effects on the unborn child or nursing infant are unknown. If you are pregnant, planning to become pregnant or breastfeeding while taking TAMIFLU, talk to your doctor before taking TAMIFLU.
• If you have any type of kidney disease, talk to your doctor before starting TAMIFLU therapy.
• The use of TAMIFLU along with an intranasal flu vaccine like FluMist®* has not been evaluated. However, due to the possibility for interference between these products, an intranasal flu vaccine should not be given within 2 weeks before or 48 hours after taking TAMIFLU, unless it is deemed appropriate by your doctor. The type of flu vaccine administered as a shot through the skin can be given at any time relative to use of TAMIFLU.

As with any medication, be sure to discuss with your doctor any over–the–counter or prescription medicines you are currently taking before beginning TAMIFLU therapy or tamiflu side effect.

The blood vessels affected include those supplying the skin, gastrointestinal tract, and central nervous system. This can result in bowel ischemia (mesenteric ischemia or ischemic colitis), chronic skin lesions, ocular lesions, strokes, spinal lesions, mononeuritis multiplex, epilepsy, headaches or cognitive disorders. Pleural or pericardial effusions are also reported.

The outcome of this disease can be fatal with a median survival of 2 to 3 years, although some appear to have a benign form (Degos acanthoma) which affects only the skin. There are fewer than fifty living patients at present known worldwide, and fewer than 200[1] reported in the medical literature. Treatment options are limited, consist mainly of Antiplatelet drugs or anticoagulants or immunosuppressants, and effect of treatment is limited to case reports.

It has been suggested that this is not a separate disorder, but the final result of several vascular systemic disorders.

The disease is named for Robert Degos who recognised it as a clinical entity in 1942, after it was first described by Kohlmeier in 1941.

What Causes Anatidaephobia?

As with all phobias, the person coping with Anatidaephobia has experienced a real-life trauma. For the anatidaephobic individual, this trauma most likely occurred during childhood.

Perhaps the individual was intensely frightened by some species of water fowl. Geese and swans are relatively well known for their aggressive tendencies and perhaps the anatidaephobic person was actually bitten or flapped at. Of course, the Far Side comics did little to minimize the fear of being watched by a duck.

While we may be tempted to smile at the memory of those comics or at the mental image of being watched by a duck, for the anatidaephobic person, that fear is uncontrollable. Whatever the cause, the anatidaephobic person can experience emotional turmoil and anxiety that is completely disruptive to daily functioning.

What Are the Symptoms of Anatidaephobia?

The symptoms of Anatidaephobia vary from person to person. Some people, when confronted with their fear, may feel slightly uncomfortable, become nauseated or begin to perspire. Others are so severely compromised by this phobia, that they experience crippling anxiety and/or panic attacks.

Other symptoms of Anatidaephobia can include:

• A Dry Mouth
• Gasping or Shortness of Breath
• Muscle Tension
• Overall Trembling
• Hyperventilation
• Feeling Out of Control
• Feeling Trapped and Unable to Escape
• Overwhelming Feeling of Impending Disaster

How Is Anatidaephobia Diagnosed?

The vast majority of cases of Anatidaephobia are self-diagnosed. The individual realizes that their fear of being watched by a duck is irrational and is severely interfering with their ability to function on a daily basis.

The sternum is sometimes cut open (a median sternotomy) to gain access to the thoracic contents when performing cardiothoracic surgery.

Structure

The sternum is composed of highly vascular tissue, covered by a thin layer of compact bone which is thickest in the manubrium between the articular facets for the clavicles.

The sternum is an elongated, flattened bone, forming the middle portion of the anterior wall of the thorax. Its upper end supports the clavicles (Collar bones), and its margins articulate with the cartilages of the first seven pairs of ribs. Its top is also connected to the Sternocleidomastoid muscle. It consists of three parts, from above downward:

• Manubrium
• Body of sternum (gladiolus)
• Xiphoid process

In its natural position, the inclination of the bone is oblique from above, downward and forward. It is slightly convex in front and concave behind; broad above, becoming narrowed at the point where the manubrium joins the body, after which it again widens a little to below the middle of the body, and then narrows to its lower extremity. Its average length in the adult is about 17 cm, and is rather longer in the male than in the female.

In early life its body is divided in three segments, called sternebrœ (singular: sternebra).

Structure

The sternum is composed of highly vascular tissue, covered by a thin layer of compact bone which is thickest in the manubrium between the articular facets for the clavicles.

• Harga 1 set Black Tourmaline Biofirion harga normal Rp 1.880.000, diskon menjadi Rp 1.200.000 FREE 1 gelang putih Biofirion
• Harga 3 set Black Tourmaline Biofirion lebih hemat menjadi Rp 3.600.000, gratis atau FREE 3 gelang putih Biofirion

Black Tourmaline Biofirion produk kesempurnaan dengan Bio Fir dan Negative Ion serta Black Tourmaline

• Melindungi tubuh dari paparan radiasi elektromagnetik
• Efektif digunakan untuk terapi arthritis
• Memperkuat system syaraf
• Meningkatkan konsentrasi dan menjaga keseimbangan emosi
• Melegakan ketegangan
• Melancarkan peredaran darah
• Meningkatkan vitalitas serta system kekebalan tubuh

Black Tourmaline telah dikenal di Eropa dan di Asia terutama di Jepang, karena fungsi dan khasiatnya

Untuk Promo Kalung Biofirion berlaku sejak tanggal 1 Oktober hingga 30 Oktober 2009

• Dapatkan potongan harga senilai Rp 300.000,- (harga normal Rp1.880.000,00), untuk pembelian 1 item atau 1 set (satu kalung dan gelang kesehatan Biofirion)
• Gratis bea kirim ke seluruh Indonesia

Atau

• Gratis 2 (dua) Gelang Biofirion setiap pembelian 1 Set Kalung Biofirion senilai Rp 1.880.000,-
• Gratis 1 (satu) set Kalung Biofirion setiap pembelian 3 Set Kalung Biofirion senilai Rp 4.440.000,-
• Gratis bea kirim ke seluruh Indonesia

Untuk Promo Biofir Surabaya Hot Sale 2009, berlaku sejak tanggal 2 Oktober hingga 2 November 2009

• Setiap pembelian 1 item atau 1 set (satu kalung dan gelang kesehatan Biofir). Dapatkan potongan harga sebesar Rp 200.000,- (dua ratus ribu rupiah untuk all item kecuali Biofirion).
• Gratis bea kirim ke seluruh wilayah Indonesia

Order segera call atau sms sebelum kehabisan…

• Suhendra, 08123157227
• Rek Bca 3290162032
• Atas Nama : Suhendra
• Bca KCP: Baliwerti, Surabaya
• Atau pembelian langsung ke Jl. Jemursari Timur 5 blok JI 20, Surabaya, 60237

Promo ini didukung juga oleh Japan-Biofir.com

• Nyeri. Jika otot tidak mendapatkan cukup darah (suatu keadaan yang disebut iskemi), maka oksigen yang tidak memadai dan hasil metabolisme yang berlebihan menyebabkan kram atau kejang. Angina merupakan perasaan sesak di dada atau perasaan dada diremas-remas, yang timbul jika otot jantung tidak mendapatkan darah yang cukup. Jenis dan beratnya nyeri atau ketidaknyamanan ini bervariasi pada setiap orang. Beberapa orang yang mengalami kekurangan aliran darah bisa tidak merasakan nyeri sama sekali (suatu keadaan yang disebut silent ischemia).
• Sesak nafas merupakan gejala yang biasa ditemukan pada gagal jantung. Sesak merupakan akibat dari masuknya cairan ke dalam rongga udara di paru-paru (kongesti pulmoner atau edema pulmoner).
• Kelelahan atau kepenatan. Jika jantung tidak efektif memompa, maka aliran darah ke otot selama melakukan aktivitas akan berkurang, menyebabkan penderita merasa lemah dan lelah. Gejala ini seringkali bersifat ringan. Untuk mengatasinya, penderita biasanya mengurangi aktivitasnya secara bertahap atau mengira gejala ini sebagai bagian dari penuaan.
• Palpitasi (jantung berdebar-debar)
• Pusing & pingsan. Penurunan aliran darah karena denyut atau irama jantung yang abnormal atau karena kemampuan memompa yang buruk, bisa menyebabkan pusing dan pingsan.